Dr. Centor links to a NY Times article asking whether the Vioxx findings are a class effect. He also ends condemning direct-to-consumer advertising:
I would hold Vioxx up as a clear example of the dangers of DCA. DCA tries to spur demand. It did. And now Merck will probably pay. And maybe some patients have paid dearly.
